Invention Grant
- Patent Title: JAK PI3K/mTOR combination therapy
- Patent Title (中): JAK PI3K / mTOR联合治疗
-
Application No.: US13571525Application Date: 2012-08-10
-
Publication No.: US09358229B2Publication Date: 2016-06-07
- Inventor: Alessandro M. Vannucchi , Costanza Bogani , Niccolo Bartalucci
- Applicant: Alessandro M. Vannucchi , Costanza Bogani , Niccolo Bartalucci
- Applicant Address: CH Basel US DE Wilmington
- Assignee: Novartis Pharma AG,Incyte Corporation
- Current Assignee: Novartis Pharma AG,Incyte Corporation
- Current Assignee Address: CH Basel US DE Wilmington
- Agency: Lathrop & Gage LLP
- Agent Brian C. Trinque
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/4745
Abstract:
Provided herein is a combination therapy comprising a JAK kinase inhibitor and a dual PI3K/mTOR inhibitor, as well as methods of treating various cancers through the use of such a combination therapy.
Public/Granted literature
- US20130040973A1 JAK PI3K/mTOR COMBINATION THERAPY Public/Granted day:2013-02-14
Information query
IPC分类:
